Countdown to Ethereum Pectra Upgrade Activation: Learn more
$2.57T
Total marketcap
$269.78B
Total volume
BTC 60.41%     ETH 7.27%
Dominance

NanoString NSTG Stock

0.11 USD {{ price }} -37.433200% {{change_pct}}%
Exchange
NasdaqGM
Market Cap
0 USD
LOW - HIGH [24H]
0.1 - 0.14 USD
VOLUME [24H]
21.43M USD
{{ volume }}
P/E Ratio
0
Earnings per share
0 USD

NanoString Price Chart

NanoString NSTG Financial and Trading Overview

NanoString stock price 0.11 USD
Previous Close 0.17 USD
Open 0.13 USD
Bid 0 USD x 0
Ask 0 USD x 0
Day's Range 0.1 - 0.14 USD
52 Week Range 0.04 - 11.02 USD
Volume 21.43M USD
Avg. Volume 17.91M USD
Market Cap 5.07M USD
Beta (5Y Monthly) 1.243
PE Ratio (TTM) N/A
EPS (TTM) 0 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est 0.25 USD

NSTG Valuation Measures

Enterprise Value 154.02M USD
Trailing P/E N/A
Forward P/E -0.06343374
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 0.031185841
Price/Book (mrq) N/A
Enterprise Value/Revenue 0.948
Enterprise Value/EBITDA -1.037

Trading Information

NanoString Stock Price History

Beta (5Y Monthly) 1.243
52-Week Change -99.21%
S&P500 52-Week Change 24.35%
52 Week High 11.02 USD
52 Week Low 0.04 USD
50-Day Moving Average 0.4 USD
200-Day Moving Average 2.15 USD

NSTG Share Statistics

Avg. Volume (3 month) 17.91M USD
Avg. Daily Volume (10-Days) 5.19M USD
Shares Outstanding 48.12M
Float 39.41M
Short Ratio 6.63
% Held by Insiders 3.16%
% Held by Institutions 106.45%
Shares Short 6.04M
Short % of Float 16.66%
Short % of Shares Outstanding 12.55%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) September 30, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin -102.43%
Operating Margin (ttm) -75.83%
Gross Margin 35.72%
EBITDA Margin -91.39%

Management Effectiveness

Return on Assets (ttm) -30.87%
Return on Equity (ttm) -1028.55%

Income Statement

Revenue (ttm) 162.47M USD
Revenue Per Share (ttm) 3.44 USD
Quarterly Revenue Growth (yoy) 62.79%
Gross Profit (ttm) 58.04M USD
EBITDA -148488992 USD
Net Income Avi to Common (ttm) -166431008 USD
Diluted EPS (ttm) -3.53
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 97.1M USD
Total Cash Per Share (mrq) 2.02 USD
Total Debt (mrq) 247.7M USD
Total Debt/Equity (mrq) N/A
Current Ratio (mrq) 2.732
Book Value Per Share (mrq) -1.051

Cash Flow Statement

Operating Cash Flow (ttm) -114977000 USD
Levered Free Cash Flow (ttm) -81480752 USD

Profile of NanoString

Country United States
State WA
City Seattle
Address 530 Fairview Avenue North
ZIP 98109
Phone 206 378 6266
Website https://www.nanostring.com
Industry Medical Instruments & Supplies
Sector(s) Healthcare
Full Time Employees 550

NanoString Technologies, Inc. develops, manufactures, and sells technology for scientific and clinical information in the fields of genomics and proteomics in the Americas, Europe, the Middle East, and the Asia Pacific. The company offers nCounter Analysis System, an automated, multi-application, digital detection, and counting system. It provides nCounter Pro and FLEX systems that include Prep Station, an automated liquid handling component that processes and prepares samples for data collection; and nCounter Digital Analyzer, which collects data from samples by taking images of the immobilized fluorescent reporters in the sample cartridge and processing the data into output files. The company also offers nCounter SPRINT Profiler, an instrument that provides liquid handling steps and the digital analysis through use of a microfluidic cartridge; and nSolver Analysis Software, a data analysis program that enables researchers to check, normalize, and analyze their data. In addition, it provides custom CodeSets; panels with oncology, immunology and infectious disease, and neuroscience applications. Further, the company offers Master Kits, cartridges, ancillary reagents, tips and reagent plates to setup and process samples in instruments; and Prosigna in vitro diagnostic kits. The company is also developing GeoMx DSP system to enable the field of spatial biology. It has collaboration with Lam Research Corporation for the development of NGS sequencing platform and related assays; and Parker Institute for Cancer Immunotherapy to develop CAR-T regimens that enhances patient outcomes for various types of cancer, as well as collaboration with Stanford Medicine, Acrobat Genomics, and Illumina Accelerator to discover new drug targets for gene editing-based therapeutics. NanoString Technologies, Inc. was incorporated in 2003 and is headquartered in Seattle, Washington. On February 4, 2024, NanoString Technologies, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.

Q&A For NanoString Stock

What is a current NSTG stock price?

NanoString NSTG stock price today per share is 0.11 USD.

How to purchase NanoString stock?

You can buy NSTG shares on the NasdaqGM exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for NanoString?

The stock symbol or ticker of NanoString is NSTG.

Which industry does the NanoString company belong to?

The NanoString industry is Medical Instruments & Supplies.

How many shares does NanoString have in circulation?

The max supply of NanoString shares is 0.

What is NanoString Price to Earnings Ratio (PE Ratio)?

NanoString PE Ratio is now.

What was NanoString earnings per share over the trailing 12 months (TTM)?

NanoString EPS is 0 USD over the trailing 12 months.

Which sector does the NanoString company belong to?

The NanoString sector is Healthcare.

NanoString NSTG included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
{{ item.name }} {{ item.symbol }} {{ item.price }} {{ item.price_usd }}
{{ item.change_pct }}
{{ item.volume }} {{ item.volume_usd }} {{ item.low }} {{ item.low_usd }} {{ item.high }} {{ item.high_usd }} {{ item.components_count }} {{ item.volume }} {{ item.volume_usd }}
NASDAQ Composite IXIC 15574.35 USD
-0.09
6.67B USD 14784.03 USD 16292.28 USD 6.67B USD
NASDAQ Biotechnology Total Retu XNBI 4143.23 USD
-1.92
4004.28 USD 4291.75 USD
NASDAQ Global Market Composite NQGM 1635.49 USD
-0.75
1547.55 USD 1705.12 USD
NASDAQ Biotechnology NBI 3839.81 USD
-1.65
3700.88 USD 3966.57 USD
NASDAQ HealthCare IXHC 863.86 USD
-0.68
828.4 USD 890 USD
NASDAQ Composite Total Return I XCMP 19020.54 USD
-0.31
18095.83 USD 19941.93 USD
Stlmt ID NASDAQ Biotechnology NBX 4153.28 USD
+1.21
4281.91 USD 4648.11 USD

Stocks Related By Sector

Stocks Related By Industry

Stocks Related By Marketcap